delineated divergent prognostic associations: SMARCA4 overexpression correlates with tumour invasiveness, whereas elevated SMARCA2 expression marks benign differentiation states—a dichotomy particularly pronounced in HCC [21]. This evidence concerns the gene SMARCA2 and hepatocellular carcinoma.